Scarica l'app Stockscreener
1.02
20.11%
0.1708
Pre-mercato:
.96
-0.06
-5.88%
Precedente Chiudi:
$0.8492
Aprire:
$1.03
Volume 24 ore:
45.02M
Relative Volume:
8.94
Capitalizzazione di mercato:
$617.76K
Reddito:
$75,000
Utile/perdita netta:
$-42.41M
Rapporto P/E:
-0.00567
EPS:
-179.8206
Flusso di cassa netto:
$-18.47M
1 W Prestazione:
+9.55%
1M Prestazione:
-50.24%
6M Prestazione:
-98.29%
1 anno Prestazione:
-99.95%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.70
$1.35
Portata 52W:
$0.70
$3,000.00
Profusa Inc Stock (PFSA) Company Profile
Nome
Profusa Inc
Settore
Industria
Telefono
212-494-9022
Indirizzo
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
1.02 | 617.76K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Borsa (PFSA) Ultime notizie
Profusa, Inc. Announces $769K Senior Secured Convertible Note Issuance to Ascent Partners - Kalkine Media
Profusa Shareholders Endorse Reverse Stock Split Authorization Ranging from 1-for-2 to 1-for-12 - kalkinemedia.com
Profusa CEO Jack E. Stover Reports Zero Shares Held Following Two $0 Transactions on August 21, 2026 - kalkinemedia.com
Profusa (PFSA) CFO shifts stake from sponsor to direct - Stock Titan
Profusa (PFSA) CEO restructures 334K-share holding - Stock Titan
PROFUSA INC (PFSA) Stock Chart - ChartMill
Profusa Issues $329,670 Senior Secured Convertible Note to Ascent; $300,000 Proceeds, 7% Interest - TradingView
Profusa issues USD 329,670 senior secured convertible note to Ascent Partners Fund - Bitget
Profusa Announces September 18 Virtual Special Meeting to Approve Reverse Stock Split Plan - Kalkine Media
Profusa regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Profusa regains compliance with Nasdaq listing requirements By Investing.com - Investing.com India
Profusa Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Profusa regains compliance with Nasdaq listing requirements - Investing.com
Profusa Regains Nasdaq Compliance for Publicly Held Shares Requirement - Minichart
Profusa Receives Nasdaq Notice on Publicly Held Shares Requirement, Compliance Confirmed and Review Closed - Quiver Quantitative
Profusa regains compliance with Nasdaq listing requirements By Investing.com - Investing.com UK
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement - Yahoo Finance
HRT Financial LP Reduces Stake in Profusa Inc (PFSA) Amid Deteriorating Fundamentals - GuruFocus
Profusa amends financing deal, resets debt conversion price at $1.07 per share - Bitget
Profusa Raises $714K Via Convertible Note, Moves to Exchange $6.14M Debt for Preferred With Ascent - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Profusa net hits USD 8.8M in Q2 2026 - Medical Buyer
Profusa shares drop 28% amid Q2 loss, reverse s... - Pluang
Profusa Announces Q2 2026 Financial Results a - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens - Yahoo Finance
Profusa converts $4.6M debt to preferred stock ahead of G3 deal - Investing.com Australia
Profusa Reports Q2 Net Loss Widens to $8.8M Amid G3 Option Deal Progress - Minichart
Profusa converts $4.6M debt to preferred stock ahead of G3 deal - Investing.com
Profusa reports Q2 2026 net loss of $8.8M; stockholders’ equity expected $28.4M after option agreement - TradingView
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company - marketscreener.com
Profusa Announces Q2 2026 Financial Results and Progress on - GlobeNewswire
Profusa Company Profile & Introduction - Moomoo
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company - The Manila Times
Profusa (PFSA) CFO converts $1.29M note into 302K shares at $4.28 - Stock Titan
Profusa (PFSA) sponsor’s $1.3M debt swap nears half the stock - Stock Titan
Profusa (PFSA) CEO turns $1.29M note into 301,991 shares - Stock Titan
NorthView Sponsor I, LLC Discloses Investment at Profusa, Inc. with 49.9% Stake - TradingView
Profusa Cash Drops to $719K, Digital Assets Eliminated - Minichart
Profusa, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HRT Financial LP sells $109,266 of Profusa stock By Investing.com - Investing.com Nigeria
HRT Financial LP sells $109,266 of Profusa stock By Investing.com - Investing.com Canada
HRT Financial LP sells $109,266 of Profusa stock By Investing.com - Investing.com India
HRT Financial LP sells $109,266 of Profusa stock - Investing.com
HRT Financial LP sells $109,266 of Profusa stock - Investing.com
Profusa (PFSA) 10% holder cuts direct stake to zero - Stock Titan
Profusa Company Profile & Introduction - Moomoo
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s - Benzinga
Profusa, Inc. Common Stock (NASDAQ: PFSA) Share Price, PFSA Stock News, PFSA Share Price & Updates - kalkine.ca
Profusa Inc Azioni (PFSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Profusa Inc Azioni (PFSA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Aug 14 '26 |
Sale |
0.90 |
3,163 |
2,853 |
71,035 |
| HRT FINANCIAL LP | 10% Owner |
Aug 13 '26 |
Sale |
0.89 |
42,411 |
37,661 |
74,198 |
| HRT FINANCIAL LP | 10% Owner |
Aug 12 '26 |
Buy |
0.96 |
5,585 |
5,384 |
116,609 |
| HRT FINANCIAL LP | 10% Owner |
Aug 11 '26 |
Sale |
0.97 |
2,280 |
2,212 |
111,024 |
| HRT FINANCIAL LP | 10% Owner |
Aug 10 '26 |
Buy |
0.94 |
4,016 |
3,791 |
113,304 |
| HRT FINANCIAL LP | 10% Owner |
Aug 07 '26 |
Sale |
0.95 |
924 |
874 |
109,288 |
| HRT FINANCIAL LP | 10% Owner |
Aug 06 '26 |
Buy |
0.94 |
926 |
873 |
110,212 |
| HRT FINANCIAL LP | 10% Owner |
Aug 05 '26 |
Sale |
0.94 |
383 |
361 |
109,286 |
| HRT FINANCIAL LP | 10% Owner |
Aug 04 '26 |
Buy |
0.95 |
1,368 |
1,305 |
109,669 |
| HRT FINANCIAL LP | 10% Owner |
Aug 03 '26 |
Buy |
0.96 |
14,556 |
13,945 |
108,301 |
6.28%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):